WM-3835 NEW
| Price | $31 | $72 | $122 |
| Package | 1mg | 5mg | 10mg |
| Supply Ability: | 10g |
| Update Time: | 2026-07-15 |
Product Details
| Product Name: WM-3835 | CAS No.: 2229025-70-9 |
| Purity: 99.36% | Supply Ability: 10g |
| Release date: 2026/07/15 |
Product Introduction
Bioactivity
| Name | WM-3835 |
| Description | WM-3835 is a novel and high-specific small molecule inhibitor of Lysine Acetyltransferase 7 (KAT7, MYST2, HBO1) , able to potently suppressed OS cell proliferation and migration, and leads to apoptosis activation. |
| In vitro | WM-3835, a novel and high-specific small molecule HBO1 inhibitor, was able to potently suppressed OS cell proliferation and migration, and led to apoptosis activation. |
| Storage | Store at low temperature,Keep away from direct sunlight, Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 5 mg/mL (12.49 mM), Sonication is recommended. DMSO : 255 mg/mL (636.83 mM), Sonication is recommended. |
| Keywords | WM-3835 | WM3835 | WM 3835 | pOS-1 | osteosarcoma | OS) cell proliferation | MYST2 | MYLK-HOXA9 | migration | Lysine Acetyltransferase 7 | KAT7 | invasion | Inhibitor | inhibit | HistoneMethyltransferase | HistoneAcetyltransferase | Histone Methyltransferase | Histone Acetyltransferase | HBO1 | HATs | HAT | H4K12ac | H3K14ac | Apoptosis | acetyl-CoA |
| Inhibitors Related | Stavudine | Aceglutamide | Urea | Tamoxifen | Cysteamine hydrochloride | Metronidazole | Citric Acid Triammonium | Manganese chloride (tetrahydrate) | Formamide | Dimethyl phthalate | Alginic acid | Sildenafil citrate |
| Related Compound Libraries | Apoptosis Compound Library | Reprogramming Compound Library | Methylation Compound Library | Bioactive Compound Library | Membrane Protein-targeted Compound Library | Epigenetics Compound Library | Inhibitor Library | Bioactive Compounds Library Max | Fluorochemical Library | Anti-Cancer Compound Library | Anti-Cancer Active Compound Library | Anti-Hypertension Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $2970.00 |
VIP2Y
|
TargetMol Chemicals Inc.
|
2026-07-15 | |
| $99.00 |
Amikon Limited
|
2019-09-06 | ||
|
VIP2Y
|
Shaanxi Dideu New Materials Co. Ltd
|
2026-07-06 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY